NorthStar appoints new senior VP, COO

By staff writers

June 21, 2021 -- NorthStar Medical Radioisotopes appointed Frank Scholz, PhD, as its new senior vice president (VP) and chief operating officer (COO).

Scholz brings more than 20 years of experience to the job and will report to the firm's president and CEO Stephen Merrick. He will focus on production capacity, next-generation technetium-99m generators, and new products such as copper-67, actinium-225, and its SPECT imaging agent FibroScint, according to NorthStar.

Scholz has previously served as managing director at AlixPartners, Mallinckrodt Pharmaceuticals, and McKinsey, NorthStar said.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking